![Biotech strategy and nanomedicine: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Friday Dec 21, 2018
Biotech strategy and nanomedicine: the pharmaphorum podcast
For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.